Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

Authors

Institutions

Publication Details

Journal
Molecular Cancer
Published
2025-03-26
DOI
https://doi.org/10.1186/s12943-025-02275-0
Citations
6
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
5.62

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

Clare Stirzaker, Ulrike Nitz, Eva‐Maria Grischke, Oleg Gluz et al.
6 citations
Molecular Cancer
Breast Cancer Treatment Studies
5.62
article

Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

Clare Stirzaker, Ulrike Nitz, Eva‐Maria Grischke, Oleg Gluz, Matthias Christgen, Christoph Uleer, Nadia Harbeck, Bahriye Aktas, Rachel Wuerstlein, Monika Graeser, Christine zu Eulenburg, Susan J. Clark, Hans Heinrich Kreipe, Matt Trau, Darren Korbie, Michael Braun, Sherko Küemmel, Mathias Warm, Helmut Forstbauer, Enrico Pelz, John Hackmann, Claudia Schumacher
article en
6 citations

Abstract

No abstract available for this paper.
Molecular CancerVol. 24(1)
Garvan Institute of Medical Research (AU), University of Hildesheim (DE), Universität Hamburg (DE), The University of Queensland (AU), Deutsches Archäologisches Institut, Zentrale (DE), Medizinische Hochschule Hannover (DE), University Medical Center Hamburg-Eppendorf (DE), Essen University Hospital (DE), St Vincent's Clinic (AU), University Hospital Leipzig (DE), Marien Hospital Witten (DE), Kliniken Essen-Mitte (DE), Rotkreuzklinikum München (DE), LVR-Klinik für Orthopädie Viersen (DE), Atos Medical (DE), Krankenhaus Köln-Holweide (DE), Ludwig-Maximilians-Universität München (DE)
National Breast Cancer Foundation, National Health and Medical Research Council
Good health and well-being
Openalex Percentile: Top 4%
Breast Cancer Treatment Studies
5.62
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.